This paper is a review article which has systematically
gathered contemporary evidence, the best practice guidelines for the management, treatment of behavioural and
psychological symptoms of dementia and the various approaches including
pharmacological and non-pharmacological approaches. It sets out to outline the
various types of behaviour in different subtypes of dementia and a practical
approach for clinicians in managing these behaviours.
Cite this paper
Jeyapaul, P. and Manchip, S. (2014) Management guidelines for behavioural and psychotic symptoms in persons with dementia—A review article. Open Journal of Psychiatry
, 5-8. doi: 10.4236/ojpsych.2014.41002
 Ballard, C., et al. (2009) Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies a double-blind, placebo-controlled, multicentre trial. The Lancet Neurology, 8, 613-618.
 Geroldi, C., Frisoni, G.B., Bianchetti, A., Trabucchi, A. and Trabucchi, M. (1997) Drug treatment in Lewy body dementia. Dementia and Geriatric Cognitive Disorders, 8, 188-197. http://dx.doi.org/10.1159/ 000106630
 Rive, B., Grishenko, M., et al. (2010) Cost effectiveness of memantine in Alzheimers Disease in the UK. Journal of Medical Economics, 13, 371-380.
 Ballard, C., Creese, B. and Corbett, A. (2011) Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion on Drug Safety, 10, 35-43.
 Bishara, D. (2012) Drugs for dementia. Medicine, 40, 684-685. http://dx.doi.org/10.1016/j.mpmed. 2012.09.009
 Sie, M. (2010) An update on sleep disorders and their treatment. Progress in Neurology and Psychiatry, 14, 9-20. http://dx.doi.org/10.1002/pnp.162